Financial Daily from THE HINDU group of publications
Sunday, Aug 31, 2003

Investment World
Features
Stocks
Port Info
Archives

Group Sites

Investment World - Stock Markets
Markets - Commentary


Up `n' down the street

G. Madhan

Ranbaxy Labs (Rs 1,001): The stock rose 13 per cent. This has to be seen in the light of the recent approvals given by the US Food & Drug Administration for multiple drugs of the company.

Morepen Labs (Rs 16): The stock surged by a whopping 60.7 per cent on expectations that there would be a sharp increase in export demand for the company's drug `Loratidine'.

Marico Industries (Rs 214): The stock was up 22.2 per cent on the back of announcement that it would enhance its presence in skin care, hair care and on health foods.

Ipca Labs (Rs 503): The stock zoomed 39.1 per cent. The market sentiment associated with pharma stocks turned bullish this week. Several pharma stocks including Ajanta Pharma, Astrazeneca Pharma, Glenmark Pharma and Shasun Chemicals posted gains.

Polaris Software (Rs 142): The stock rose 22.6 per cent on market talk that global IT major IBM might pick up stake in the company. However, the company has denied these rumours.

Ballarpur Industries (Rs 68): The stock rose 8.5 per cent on expectation of firm trends in paper prices.

Bharti Tele Ventures (Rs 69): The stock rose 9 per cent. It may stand to gain on account of consolidation in the cellular industry following the TDSAT judgment on limited mobility.

HPCL (Rs 430): The stock rose 7.3 per cent. This rise has to be seen in the light of the due diligence process has started by bidders for its proposed disinvestment.

Dhampur Sugar (Rs 25): The stock rose 6.9 per cent. The stock has been witnessing uptrend ever since the Union Cabinet declared a package worth Rs 678 crore for sugarcane growers.

Zee Telefilms (Rs 102): The stock fell 11.8 per cent on uncertainties over implementation of Conditional Access System.

Article E-Mail :: Comment :: Syndication

Stories in this Section
San Geo: Accept


Frequently asked questions at investor depository meets
Reliance Infocomm offers international SMS
Question `n' Auto
Demergers: Dividing to multiply
When to spin off the profits
Delisted companies and minority shareholders — Using 100 for 100
SEBI must keep both eyes on the bull
Pension reforms: Flexibility essential
Derivatives and the median quarter sigma rule
Sundaram Income Plus: Invest
SBI Magnum Contra Fund: Sell
Assets under management: Jostling to level with UTI Mutual
Taurus the Starshare: Sell
DSP Merrill Equity: Pare exposure
Canbank Mutual Fund new schemes
HCL Technologies: Pare exposures
Ballarpur Industries: Book profits
Thomas Cook: Hold
Jay Bharat Maruti: Buy
Tata Tea: Hold/Buy on declines
Dalmia Cement: Still some steam left
Century Textiles: Risky, but a value play
Buy Century Textiles on declines
Query corner
Further upside likely
The Winds of change
Google launches Indian version
Kotak Mahindra Bank cuts home loan rates
LIC's Komal Jeevan
Aviva Life Insurance policy for SHGs
Healthy bout for pharma cos
Up `n' down the street
Downside bias
New entrants active
Using futures/options
CNX IT- Derivatives
Options guide
`Anywhere Banking' from Federal Bank
HDFC: Housed in strong fundamentals
Taxability of foreign-earned income
Deduction of medical expenses
Therapy for traders
Shortsell


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | Home |

Copyright © 2003, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line